5q Minus Myelodysplasia Associated with Multiple Epithelioid Granulomas within Conventional Renal Cell Carcinoma
- PMID: 22934211
- PMCID: PMC3420743
- DOI: 10.1155/2012/138126
5q Minus Myelodysplasia Associated with Multiple Epithelioid Granulomas within Conventional Renal Cell Carcinoma
Abstract
A 69-year-old Caucasian female, with a previous diagnosis of 5q minus myelodysplastic syndrome, presented with conventional renal cell carcinoma (RCC) associated with multiple-epithelioid nonnecrotizing granulomas. Two previous reports of sarcoidosis, primarily involving the lung and skin, have been described in patients with 5q minus myelodysplasia. A cluster of closely linked genes encoding for cytokines such as IL-4, IL-5, and IL-3 are present on chromosome 5q. Hence, in sarcoidosis, cytokine imbalances associated with the deletion of these cytokine genes have been postulated. However, an occurrence of epithelioid granulomas within a carcinoma, in preexisting clonal myelodysplastic syndrome, has not been described. The patient, in the current study, had long standing 5q minus deletion, clinically characterized by refractory anemia associated with hypolobated megakaryocytes. However, the patient's history was negative for sarcoidosis and the extensive nonnecrotizing epithelioid granulomas were confined within RCC. Due to the absence of Th-2 cytokines, such as IL-4 and IL-5, in a subset of 5q minus myelodysplastic syndrome, proinflammatory Th-1 cytokines such as IFN-γ and TNF-α may be exaggerated in an environment conducive to antigen expression. Hence, we propose a greater susceptibility for the development of granulomas, at least in a subset of patients with 5q minus myelodysplasia.
Figures



Similar articles
-
Sarcoidosis in a patient with 5q-myelodysplasia. A possible pathogenetic link between the two diseases.Monaldi Arch Chest Dis. 2000 Oct;55(5):378-80. Monaldi Arch Chest Dis. 2000. PMID: 11213374
-
Development of 5q- myelodysplasia in a patient with sarcoidosis.Am J Hematol. 1990 Jul;34(3):225-7. doi: 10.1002/ajh.2830340314. Am J Hematol. 1990. PMID: 2363416
-
Loss of both CSF1R (FMS) alleles in patients with myelodysplasia and a chromosome 5 deletion.Proc Natl Acad Sci U S A. 1991 Jul 15;88(14):6176-80. doi: 10.1073/pnas.88.14.6176. Proc Natl Acad Sci U S A. 1991. PMID: 1829836 Free PMC article.
-
A critical review of the molecular pathophysiology of lenalidomide sensitivity in 5q - myelodysplastic syndromes.Leuk Lymphoma. 2012 May;53(5):779-88. doi: 10.3109/10428194.2011.623255. Epub 2011 Nov 25. Leuk Lymphoma. 2012. PMID: 21955212 Review.
-
The pathology of pulmonary sarcoidosis: update.Semin Diagn Pathol. 2007 Aug;24(3):150-61. doi: 10.1053/j.semdp.2007.06.002. Semin Diagn Pathol. 2007. PMID: 17882899 Review.
References
-
- Haase D, Germing U, Schanz J, et al. New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patients. Blood. 2007;110(13):4385–4395. - PubMed
-
- Giagounidis AAN, Germing U, Aul C. Biological and prognostic significance of chromosome 5q deletions in myeloid malignancies. Clinical Cancer Research. 2006;12(1):5–10. - PubMed
-
- Tunkel AR, Sebastianelli KJ, Pandit N, Brody JI. Development of 5q—myelodysplasia in a patient with sarcoidosis. American Journal of Hematology. 1990;34(3):225–227. - PubMed
-
- Airaghi L, Montori D, Zorzi F, Miadonna A, Tedeschi A. Sarcoidosis in a patient with 5q-myelodysplasia. A possible pathogenetic link between the two diseases. Monaldi Archives for Chest Disease. 2000;55(5):378–380. - PubMed
-
- Vestey JP, Turner M, Biddlestone L, McLaren K, Goulden N, Hunter JAA. Disseminated cutaneous granulomatous eruptions associated with myelodysplastic syndrome and acute myeloid leukaemia. Clinical and Experimental Dermatology. 1993;18(6):559–563. - PubMed
LinkOut - more resources
Full Text Sources